Comparing Carvedilol vs Entresto
| Carvedilol | Entresto |
|
|---|
| Carvedilol | Entresto sacubitril / valsartan |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Carvedilol blocks both alpha and beta receptors to lower blood pressure and improve how the heart pumps blood. It is not usually recommended for people with pre-existing breathing problems... View more |
Entresto is a combination medication containing sacubitril and valsartan that may be given to treat heart failure in adults and children over the age of one. Studies have shown it to be superior to... View more |
Choose a suggestion below Heart Failure (Congestive Heart Failure)
Popular Comparisons
|
|||||||||||||||
| More about Carvedilol | More about Entresto (sacubitril / valsartan) | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
|||||||||||||||||
| Availability | |||||||||||||||||
|
Prescription only |
Prescription only |
||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Carvedilol has an average rating of 5.3 out of 10 from a total of 175 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 44% reported a negative effect. |
Entresto has an average rating of 4.7 out of 10 from a total of 165 ratings on Drugs.com. 36% of reviewers reported a positive effect, while 53% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
Commonly reported side effects include: hyperglycemia. See the full carvedilol side effects document. |
Common side effects include: hyperkalemia, hypotension, and increased serum creatinine. See the full Entresto side effects document. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all carvedilol prices |
View all Entresto prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Coreg, Coreg CR |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
3.1 hours |
11.5 hours |
||||||||||||||||
| CSA Schedule** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Summary unavailable. See the full Pregnancy Warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 519 drugs are known to interact with carvedilol:
|
A total of 280 drugs are known to interact with Entresto:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|||||||||||||||||
| First Approval Date | |||||||||||||||||
|
September 14, 1995 |
July 07, 2015 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
|||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.